HI
XENT

HBK Investments’s Intersect ENT, Inc XENT Stock Holding History

HBK Investments’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-23,085
Closed -$651K – 1440
2018
Q4 		$651K Sell
23,085
-32,315
-58% -$946K 0.01% 818
2018
Q3 		$1.59M Buy
55,400
+6,520
+13% +$196K 0.01% 589
2018
Q2 		$1.83M Buy
48,880
+32,219
+193% +$1.26M 0.01% 508
2018
Q1 		$655K Sell
16,661
-16,541
-50% -$604K ﹤0.01% 710
2017
Q4 		$1.08M Sell
33,202
-253
-0.8% -$7.59K 0.01% 595
2017
Q3 		$1.04M Sell
33,455
-4,245
-11% -$126K 0.01% 621
2017
Q2 		$1.05M Buy
+37,700
New +$854K 0.01% 558

Other funds holding XENT

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

HBK Investments's XENT Position: Q1 2019 in Review

HBK Investments sold out of Intersect ENT, Inc (XENT) in Q1 2019, closing a stake of 23,085 shares — an estimated $651K sold.

HBK Investments first reported a position in XENT in Q2 2017 and held it in 7 quarters. The position peaked at $1.83M in Q2 2018. 136 funds tracked by Wall St. Rank hold XENT as of Q1 2019.

  • HBK Investments reported no remaining Intersect ENT, Inc position as of Q1 2019 after selling out during the quarter.
  • HBK Investments sold 23,085 Intersect ENT, Inc shares in Q1 2019, an estimated $651K.
  • HBK Investments first reported a position in Intersect ENT, Inc in Q2 2017 and held it in 7 quarters.
  • HBK Investments's Intersect ENT, Inc position peaked at $1.83M in Q2 2018.
  • 136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2019.

Based on HBK Investments's 13F filing for Q1 2019, filed 15 May 2019.